Skip to main content

Table 4 Changes in health screening variables by medication

From: Changes in metabolic profiles after the Great East Japan Earthquake: a retrospective observational study

Variables

Medication group (n = 97)

No medication group (n = 103)

p valuea

Physical examination

   

Body weight (kg)

+0.3 (-1.2, +1.6)

+0.8 (-0.8, +2.9)

n.s.

BMI (kg/m2)

+0.2 (-0.6, +0.7)

+0.3 (-0.4, +0.9)

n.s.

Waist circumference (cm)

+1.5 (-2.0, +4.5)

+1.5 (-2.1, +3.2)

n.s.

Systolic blood pressure (mmHg)

+2 (-12, +14)

+4 (-8, +10)

n.s.

Diastolic blood pressure (mmHg)

-2 (-8, +4)

0 (-7, +6)

n.s.

Laboratory examination

   

HbA1c (%)

+0.2 (0.0, +0.4)

+0.2 (+0.1, +0.3)

n.s.

HDL cholesterol (mmol/L)

-0.05 (-0.18, +0.10)

-0.03 (-0.10, +0.13)

0.009

LDL cholesterol (mmol/L)

-0.05 (-0.31, +0.28)

+0.01 (-0.31, +0.24)

n.s.

Triglyceride (mmol/L)

+0.03 (-0.49, +0.65)

+0.03 (-0.46, +0.44)

n.s.

Treatment status

   

Periodic clinic visit, new

28 (28.9)

1 (1.0)

<0.001

Periodic clinic visit, discontinuation

0 (0.0)

7 (6.8)

0.009

  1. The alterations in health screening variables were evaluated with post-quake treatment status. Median of change (interquartile range) or number (percentage) is shown.
  2. n.s., not significant.
  3. aMann-Whitney U or Pearson chi-square tests were performed to compare numerical data or ratio data between the tsunami and radiation groups, respectively.
  4. p < 0.05 and p < 0.01 for paired comparison between pre-quake and post-quake values using Wilcoxon matched-pair signed-rank test (Additional file 5: Table S3).
  5. BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.